Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Approval

Lanthanum carbonate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company

DUNS: 078719707

Effective Date

June 13, 2023

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Active Ingredients

Lanthanum carbonate(500 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

InvaGen Pharmaceuticals, Inc.

Labeler

Cipla USA Inc.

DUNS Number

165104469

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lanthanum carbonate

Product Details

NDC Product Code

69097-934

Application Number

ANDA206868

Marketing Category

ANDA (C73584)

Route of Administration

ORAL

Effective Date

June 13, 2023

Ingredients

Lanthanum carbonateActive

Code: 490D9F069TClass: ACTIMQuantity: 500 mg in 1 1

GUAR GUMInactive

Code: E89I1637KEClass: IACT

SUCRALOSEInactive

Code: 96K6UQ3ZD4Class: IACT

DEXTRATESInactive

Code: G263MI44RUClass: IACT

SILICON DIOXIDEInactive

Code: ETJ7Z6XBU4Class: IACT

MAGNESIUM STEARATEInactive

Code: 70097M6I30Class: IACT

STEARIC ACIDInactive

Code: 4ELV7Z65APClass: IACT

MICROCRYSTALLINE CELLULOSEInactive

Code: OP1R32D61UClass: IACT

HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive

Code: 9XZ8H6N6OHClass: IACT

Lanthanum carbonate

Product Details

NDC Product Code

69097-936

Application Number

ANDA206868

Marketing Category

ANDA (C73584)

Route of Administration

ORAL

Effective Date

June 13, 2023

Ingredients

Lanthanum carbonateActive

Code: 490D9F069TClass: ACTIMQuantity: 1000 mg in 1 1

SUCRALOSEInactive

Code: 96K6UQ3ZD4Class: IACT

MICROCRYSTALLINE CELLULOSEInactive

Code: OP1R32D61UClass: IACT

GUAR GUMInactive

Code: E89I1637KEClass: IACT

DEXTRATESInactive

Code: G263MI44RUClass: IACT

HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive

Code: 9XZ8H6N6OHClass: IACT

SILICON DIOXIDEInactive

Code: ETJ7Z6XBU4Class: IACT

STEARIC ACIDInactive

Code: 4ELV7Z65APClass: IACT

MAGNESIUM STEARATEInactive

Code: 70097M6I30Class: IACT

Lanthanum carbonate

Product Details

NDC Product Code

69097-935

Application Number

ANDA206868

Marketing Category

ANDA (C73584)

Route of Administration

ORAL

Effective Date

June 13, 2023

Ingredients

Lanthanum carbonateActive

Code: 490D9F069TClass: ACTIMQuantity: 750 mg in 1 1

MICROCRYSTALLINE CELLULOSEInactive

Code: OP1R32D61UClass: IACT

HYDROXYPROPYL CELLULOSE, UNSPECIFIEDInactive

Code: 9XZ8H6N6OHClass: IACT

SUCRALOSEInactive

Code: 96K6UQ3ZD4Class: IACT

GUAR GUMInactive

Code: E89I1637KEClass: IACT

SILICON DIOXIDEInactive

Code: ETJ7Z6XBU4Class: IACT

DEXTRATESInactive

Code: G263MI44RUClass: IACT

STEARIC ACIDInactive

Code: 4ELV7Z65APClass: IACT

MAGNESIUM STEARATEInactive

Code: 70097M6I30Class: IACT

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy